enVVeno Medical Corp (NVNO)
NCM · Common · CUSIP 41015N106
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NVNO and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
41015N106
Market Cap
Micro Cap
IPO
5/31/2018 · $5.00/share
Previous Symbol
HJLI (changed 10/1/2021)
Previous Name
Hancock Jaffe Laboratories, Inc.
Business: enVVeno Medical Corp is a late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company’s lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI).

Company Contact

CEO
Robert A. Berman
CFO
Craig Glynn
Headquarters
70 Doppler, Irvine, CA 92618
Phone
949-261-2900 · Toll-Free 833-475-8247
Fax
949-261-2992
Investor Relations
Jenene Thomas, JTC Team · 833-475-8247 · nvno@jtcir.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »
Find all related securities for NVNO »